Zymeworks (ZYME) Change in Accured Expenses (2021 - 2026)

Zymeworks has reported Change in Accured Expenses for 6 years, with the latest figure at -$7.8 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 63.48% year-over-year to -$7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.2 million (down 10.93% YoY) and the FY2025 annual result came in at -$23.6 million, down 265.13% from the prior year.
• Change in Accured Expenses slipped to -$7.8 million in Q1 2026 per ZYME's latest filing, from $1.3 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $37.6 million in Q4 2022 and troughed at -$28.3 million in Q1 2023.
• A 5-year average of -$2.1 million and a median of $1.3 million in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses soared 551.75% in 2022, then tumbled 1031.47% in 2025.
• Over 5 years, Change in Accured Expenses stood at $37.6 million in 2022, then sank by 159.42% to -$22.3 million in 2023, then soared by 132.87% to $7.3 million in 2024, then tumbled by 81.8% to $1.3 million in 2025, then slumped by 680.52% to -$7.8 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$7.8 million, $1.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.